PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 217 filers reported holding PTC THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,007,000 | +30.6% | 16,500 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $771,000 | -54.8% | 16,500 | -50.9% | 0.00% | 0.0% |
| Q2 2020 | $1,704,000 | +48.7% | 33,600 | -51.1% | 0.00% | -40.0% |
| Q4 2017 | $1,146,000 | -57.1% | 68,700 | -48.5% | 0.01% | -54.5% |
| Q3 2017 | $2,669,000 | -9.9% | 133,400 | -17.5% | 0.01% | -15.4% |
| Q2 2017 | $2,962,000 | +2775.7% | 161,600 | +1439.0% | 0.01% | – |
| Q1 2017 | $103,000 | -94.5% | 10,500 | -84.9% | 0.00% | -100.0% |
| Q3 2015 | $1,858,000 | -45.7% | 69,581 | -2.1% | 0.01% | -42.9% |
| Q2 2015 | $3,420,000 | -20.9% | 71,053 | 0.0% | 0.01% | -22.2% |
| Q1 2015 | $4,324,000 | +26.5% | 71,053 | +7.6% | 0.02% | +28.6% |
| Q4 2014 | $3,419,000 | +25.7% | 66,036 | +6.8% | 0.01% | +16.7% |
| Q3 2014 | $2,720,000 | +68.3% | 61,810 | 0.0% | 0.01% | +71.4% |
| Q2 2014 | $1,616,000 | – | 61,810 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayer Capital Management, LP | 416,666 | $7,153,000 | 38.92% |
| Novo Holdings A/S | 747,359 | $11,210,000 | 2.78% |
| Bain Capital Public Equity Management, LLC | 2,333,333 | $50,073,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,027 | $18,134,000 | 0.84% |
| HealthCor Management, L.P. | 732,200 | $15,713,000 | 0.84% |
| RA Capital Management | 300,000 | $6,438,000 | 0.67% |
| Catalyst Capital Advisors LLC | 30,666 | $658,000 | 0.36% |
| CR Intrinsic Investors, LLC | 119,237 | $2,559,000 | 0.08% |
| Weiss Multi-Strategy Advisers LLC | 284,130 | $6,098,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 57,519 | $1,234,000 | 0.06% |